Comments on: Real World Study of FDA approved Alzheimer’s Disease Drugs: Pause for ?Concern

By: Joel Ross

Joel Ross — Fri, 19 Feb 2010 22:00:25 +0000

I am glad in some small way I am helping Bill. He is the one person I can truly say that was responsible for recruing me from an ad he ran in the December New England Journal of Medicine, 1985. I read it, we met in NYC first and then to Long Branch. I do hope we can find a way to slow his decline.
Let me know if I can be of any further help. The medical center at Yale has a superb group of geriatricians.
Would you want me to reach out to them for another opinion?
Kindest personal regards, Joel
mobile: 908.489.8760

By: Joel Ross

Joel Ross — Fri, 19 Feb 2010 21:58:08 +0000

Thanks for the continued support and interest Regina. I am planning an AD prevention study for children of pts with AD who carry the gene known as Apoe4. Kindest personal regards, Joel

By: Sally Vaun

Sally Vaun — Fri, 05 Feb 2010 21:00:15 +0000

Joel thank you so much for putting this article on the website. It makes me feel much better about my husband refusing to take any of these drugs which were prescribed for his disease.
Sally

By: Regina Thomas

Regina Thomas — Fri, 05 Feb 2010 14:58:28 +0000

Joel– Thank you so much for bringing this article to your subscribers’ attention. It is MOST helpful and supports my claim, certainly re Exelon in my case (I was on it for 3 mos. with the patch when it first came out). More importantly, it strengthens my argument that Art Larsen should be tken off the Aricept that his neurologist prescribed for him about two months ago. He has gotten even more confused and is very tired all the time. His daughter noticed it when she was here last week seeing him for the first time since her wedding five months ago. I’ve emailed both his daughters the article and encouraged them to follow through with Art’s neurologist (whom he just saw a few days ago and said (according to Art) “he hasn’t given the medicine enough time to do its work.” I say B-S.

Regina